deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04338750

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Dementia (TACTICs)

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Alzheimer's Disease and Related Dementias (TACTICs): A Pilot Randomized Controlled Trial

Sponsor: Indiana Clinical and Translational Sciences Institute

Updated 6 times since 2020 Last updated: Jul 23, 2022 Started: Mar 24, 2020 Primary completion: Apr 9, 2021 Completion: Apr 9, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anxiety and Anxiety Disorders and Symptoms and is currently completed. Indiana Clinical and Translational Sciences Institute leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~May 2020 – ~Jan 2021 · 8 months · monthly snapshotRecruiting~Jan 2021 – ~May 2022 · 16 months · monthly snapshotRecruiting~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Sep 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted · Phase: PHASE2NA

  4. May 2022 — Sep 2022 [monthly]

    Unknown Status PHASE2

    Status: RecruitingUnknown Status

  5. Jan 2021 — May 2022 [monthly]

    Recruiting PHASE2

Show 1 earlier version
  1. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Indiana Clinical and Translational Sciences Institute
  • Indiana University
  • Regenstrief Institute, Inc.
Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations